SEC Form 4 · accession 0001867666-26-000009
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Louis H. Morrone
Officer — EXECUTIVE VICE PRESIDENT
Period of report
Jun 30, 2026
Accepted (ET)
Jul 1, 2026 · 5:04 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Jun 30, 2026 | F | 269 | $92.71 | D | 76,574 | D | |
| Common shares without par valueF1 | holding | — | — | — | 12 | I | Profit Sharing Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Balance in the Abbott Laboratories Stock Retirement Trust as of June 30, 2026.